CCL2 and prostate carcinoma: Bone marrow endothelial cells were shown to secrete considerably higher levels of CCL2 compared to aortic and dermal endothelial cells, leading to preferential recruitment of prostate cancer cells to the bone and local support of their proliferation [107].